Ninewells Hospital
- Advisory Board: Eli Lilly and Company; Flynn; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka America Pharmaceuticals, Inc.; Pfizer Inc.; Schering-Plough; Shire Pharmaceuticals Inc.; UCB; Vifor Pharma Ltd.
- Consultant: Shire Pharmaceuticals Inc.
- Grant Support: Eli Lilly and Company; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Shire Pharmaceuticals Inc.; Vifor Pharma Ltd.
- Honorarium for participation in another meeting: Eli Lilly and Company; Flynn; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Medice; Novartis Pharmaceutical Corporation; Shire Pharmaceuticals Inc.
- Research Support: Eli Lilly and Company; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Shire Pharmaceuticals Inc.; Vifor Pharma Ltd.
- Royalties: Oxford University Press
- Speakers Bureau: Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Shire Pharmaceuticals Inc.
- Travel Support for participation in another meeting: Eli Lilly and Company; Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Shire Pharmaceuticals Inc.
- Travel Support to attend this meeting: Shire Pharmaceuticals Inc.